Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences

Takeda has signed a global licensing and research collaboration agreement with South Korean company LG Life Sciences to discover, develop and commercialize anti-obesity drugs, the firms announced March 30